Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

• Meletios A. Dimopoulos,
• Philippe Moreau,
• Evangelos Terpos,
• María-Victoria Mateos,
• Sonja Zweegman,
• Gordon Cook,
• Michel Delforge,
• Roman Hájek,
• Fredrik Schjesvold,
• Michele Cavo,
• Hartmut Goldschmidt,
• Thierry Facon,
• Hermann Einsele,
• Mario Boccadoro,
• Jesús San-Miguel,
• Pieter Sonneveld,
• Ulrich Mey,
• on behalf of the EHA Guidelines Committee and the ESMO Guidelines Committee

Affiliations

Meletios A. Dimopoulos

1 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece

Philippe Moreau

2 Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France

Evangelos Terpos

1 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece

María-Victoria Mateos

3 University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain

Sonja Zweegman

4 Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, The Netherlands

Gordon Cook

5 Leeds Cancer Centre and University of Leeds, United Kingdom

Michel Delforge

6 Department of Hematology, University Hospital Leuven, Belgium

Roman Hájek

7 Faculty of Medicine, University Hospital Ostrava, Czech Republic

Fredrik Schjesvold

8 Oslo Myeloma Center, Oslo University Hospital, Oslo, Norway

Michele Cavo

10 Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Hartmut Goldschmidt

11 University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany

Thierry Facon

12 Hôpital Claude Huriez, Lille University Hospital, Lille, France

Hermann Einsele

13 Department of Internal Medicine II, University Hospital Wurzburg, Germany

Mario Boccadoro

14 Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Italy

Jesús San-Miguel

15 Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain

Pieter Sonneveld

16 Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands

Ulrich Mey

17 Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.

on behalf of the EHA Guidelines Committee and the ESMO Guidelines Committee